Monica had done this before.
First cycle: two days of bloating, back at her desk by day three, no problems.
Second cycle: three days in, she couldn't get off the couch.
She called the clinic frantic, expecting alarm.
Instead, the nurse asked if she was drinking enough water.
That flat voice is where the doubt started.
The Call That Didn't Match the Warning
She'd been told OHSS was rare, a small chance, nothing to worry about.
So when her stomach swelled and she couldn't breathe lying flat, she called scared.
The nurse on the phone sounded almost bored.
There was no sharp intake of breath, no urgency in her voice.
Just drink more water, take the painkillers, give it time.
That calm is what stuck with Monica after she hung up.
If this was rare, why did the nurse sound like she'd heard it a hundred times before.
A Smooth First Cycle Told Her Nothing
Monica's first donation went so easily she barely thought about the risks again.
Two days of bloating, mild cramping, back at her desk by day three.
She assumed her body had just handled it well.
Nobody corrected that assumption before her second cycle started.
A good first cycle predicts almost nothing about the second one.
Her dose went up, and so did everything else.
Nobody explained why the dose changed before she agreed to it.
Nobody Explained the Dose Increase
She didn't ask why her medication dose was higher the second time.
Nobody offered to explain it either.
Clinics call this a routine adjustment.
Monica calls it the thing that put her in a hospital gown.
A higher dose can mean more follicles, more eggs, more hormone in her system.
More hormone is what drives ovarian hyperstimulation in the first place.
Nobody connected those two facts for her before she signed on again.
What Rare Actually Means Depends on Who's Counting
The American Society for Reproductive Medicine puts severe OHSS at 1 to 2 percent.
That figure sounds small, almost forgettable.
It only counts the severe cases, the ones that land someone in a hospital.
The UK's HFEA cites a very different number for milder cases.
About a third of donors get some degree of mild OHSS, by that count.
One clinic's rare and one donor's routine are not describing the same thing.
Nobody puts both numbers on the same intake form.
A donor googling "OHSS rate" the night before her consent appointment will find both, with no context for which one applies to her.
The Forums Say One in Three, Not One in Fifty
Search any donor forum for OHSS and the numbers stop matching the pamphlet.
Women cite 9 percent, 33 percent, even 39 percent depending on the thread.
Skeptics point out forums attract people with bad experiences, not the smooth cases.
That is a fair point, and it is not the whole story either.
A third of donors reporting mild symptoms, by HFEA's own count, is not a fringe outlier.
It is closer to what women describe online than what the 1 to 2 percent figure suggests.
Two true numbers, measuring two different things, still leave a donor with nothing solid to plan around.
Even a careful reader comparing sources side by side will find the methodology buried, if it's stated at all.
The Symptoms Clinics Call Normal Recovery
Bloating is expected, clinics say, and so is some discomfort.
One donor described her abdomen as the size of a basketball.
Another said her stomach looked five months pregnant, painful to the touch.
A third put it plainly: she felt six months pregnant for days.
None of them were told that this could be a warning sign.
They were told it was recovery.
When It Turns Severe, It Turns Fast
Some donors go from fine to frightening within a day.
One had 43 eggs retrieved and was in the ER the next morning.
Another described bubbles around her collarbone as fluid pressed on her lungs.
A donor with 53 eggs retrieved ended up in a medical coma, four days in the ICU.
One flew home while still feeling severely ill and had a stroke, ten days hospitalized.
These are not the outcomes anyone pictures when a nurse says drink water.
If your symptoms escalate this fast, waiting to see if it passes is the wrong bet.
Egg Yield Is the Number Nobody Connects Until After
Donors rarely know their retrieval count in advance.
One woman learned she'd produced 63 eggs only after her symptoms had already turned severe.
By then the number was not useful, just alarming.
Higher yields tend to track with worse reactions, though nobody frames it that way beforehand.
A donor going into a second cycle with a raised dose is walking toward a higher number.
Nobody tells her that is what the raised dose is actually for.
Why the Second Cycle Can Be Worse Than the First
This is Monica's exact question, and it deserves a straight answer.
A higher dose means more stimulation, which means more risk of overshoot.
One clinic reportedly blamed a donor's severe reaction on her being super fertile, not on the dosing.
That framing puts the risk on her body instead of on the decision to raise the dose.
A nurse who had also donated described her own second reaction as terrifying, near-fatal.
She was not a stranger to the process, and it still caught her off guard.
An easy first cycle protects nobody from that.
The Question Clinics Don't Want to Answer First
Ask a clinic for your risk and you will likely get the population number, not yours.
What Monica actually needs is a number tied to her profile, her dose, her history.
One donor said her only warning was being told she might be at risk on the day of the trigger.
That is not disclosure delivered in time to matter.
If a donor ends up in the ER, she is often left figuring out who pays.
That uncertainty should not exist before a decision this big.
If the clinic will not name what changed in her protocol, that is the answer in itself.
What Actually Lowers the Risk the Second Time
There is a protocol change that genuinely lowers OHSS risk, not just paperwork reassurance.
A GnRH-agonist trigger, instead of the standard one, cuts the odds measurably.
Evidence for this has existed for a while.
Plenty of donors say nobody offered it to them, or explained why it was not used.
One researcher surveying donors found 15 reporting moderate to severe OHSS, out of a small group.
Groups like We Are Egg Donors exist because donors kept comparing notes and finding the same gaps.
That is where the cycle-specific questions get asked, before a contract, not after a hospital stay.
Even donors who fact-check every statistic they find land here eventually, because the studies alone do not settle it.
The Choice Monica Is Actually Making
A third cycle might be fine.
It might also come with another dose increase and another set of symptoms nobody named in advance.
One survivor of two severe reactions called herself extremely lucky to have made it through both.
Luck is not a plan.
Monica does not need a bigger number or a smaller one.
She needs someone to explain what changed, and why, before she signs anything else.
A clinic that cannot answer that has already told her what she needs to know.